Topiramate Safety in Patients Taking Two Antidepressants

Introduction to Topiramate and Antidepressant Combinations

The American Academy of Child and Adolescent Psychiatry recommends starting topiramate at a low dose and increasing slowly to minimize adverse effects when adding it to a regimen with two antidepressants 3
The American Gastroenterological Association notes that topiramate has been safely used in patients taking SSRIs and SNRIs, as clinical trials for obesity treatment specifically included patients with depression on these medications 1, 2

The American Academy of Child and Adolescent Psychiatry suggests monitoring closely during the first 24-48 hours after dosage changes, as this is when serotonin syndrome symptoms are most likely to appear 3, 4
Symptoms of serotonin syndrome include mental status changes, neuromuscular hyperactivity, and autonomic hyperactivity, and advanced symptoms requiring immediate medical attention include fever, seizures, arrhythmias, and unconsciousness 3, 4

The American Gastroenterological Association recommends beginning with a low dose (25-50 mg/day) and titrating slowly over several weeks 6, 5
For weight management in patients on antidepressants, phentermine/topiramate ER starting at 3.75/23 mg daily is recommended, with gradual titration as tolerated 6

The American Gastroenterological Association notes that patients with migraine headaches may particularly benefit from topiramate in addition to their antidepressant regimen 6
The American Gastroenterological Association recommends monitoring serum bicarbonate periodically due to topiramate's carbonic anhydrase inhibition properties 5
The American Gastroenterological Association advises avoiding topiramate in patients with untreated hyperthyroidism due to risk of arrhythmias and seizures, and using it with caution in patients with a history of kidney stones due to increased risk from carbonic anhydrase inhibition 5